Filter
991
Featured
127
321
Language
Document type
716
109
86
33
15
14
10
5
3
Countries
83
41
30
25
25
24
23
22
19
18
13
13
12
12
12
11
11
10
10
9
9
9
8
7
7
6
6
5
5
4
4
4
4
4
4
4
4
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
380
149
42
33
11
11
9
Toolboxes
274
168
54
26
24
13
11
10
10
9
8
6
5
5
5
5
3
3
3
2
1
In many low- and middle-income countries, there is a wide gap between evidencebased recommendations and current practice. Treatment of major CVD risk factors remains suboptimal, and only a minority of patients who are treated reach their target levels for blood pressure, blood sugar and blood choles
...
Anema et al. AIDS Research and Therapy 2011, 8:13 http://www.aidsrestherapy.com/content/8/1/13
The aim of the people-centred framework is to help countries to develop fully prioritized and budgeted NSPs based on a culture of making full use of the available data, which are aligned with national planning cycles and which provide the basis for a robust national response that can accelerate prog
...
Research Article
PLOS ONE | https://doi.org/10.1371/journal.pone.0190785 January 10, 2018
Technical Brief
Accessed: 07.11.2019
UNAIDS/10.03E / JC1767E (English original, March 2010) ISBN 978 92 9 173849 6
12-13 December 2016
Global Action Plan on HIV Drug Resistance - Webinars 12-13 December 2016
WHO
Considering programmatic implications of rising levels of HIV drug resistance: finalizing the Global Action Plan
Webinars 12 13 Dec 2016
WHO recommends that pre-exposure prophylaxis (PrEP) be offered as an additional prevention choice for HIV-negative individuals at substantial risk of HIV infection as part of combination prevention approaches.
HIV drug resistance has been rarely reported among PrEP users who tested HIV positive i
...
Technical Report
Guidelines
June 2017
HIV strategic information for impact
3rd Edition – July 2017
www.msfaccess.org
Strengthening Community responses to HIv Treatment and Prevention
